Sense Proteomic Overview

  • Founded
  • 1998
  • Status
  • Acquired/​Merged
  • Employees
  • 10
  • Latest Deal Type
  • M&A

Sense Proteomic General Information


Developer of proprietary technology to discover and commercialise auto antibody biomarkers. The company offers biomaker panels for use with cancer and autoimmune disease patients.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • Unit 4
  • The Switchback Gardner Road
  • Maidenhead Berkshire SL6 7RJ
  • England, United Kingdom
+44 01628 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sense Proteomic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 17-Mar-2009 Completed Generating Revenue
4. Spin-Off 04-Jun-2008 Completed Generating Revenue
3. Merger/Acquisition 16-Jan-2003 Completed Startup
2. Early Stage VC 28-Jan-2002 Completed Startup
1. Spin-Off 19-Nov-1998 Completed Startup
To view Sense Proteomic’s complete valuation and funding history, request access »

Sense Proteomic Patents

Sense Proteomic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150204866-A1 Auto-antigen biomarkers for lupus Abandoned 02-Aug-2012 0000000000 0
EP-2880445-A1 Auto-antigen biomarkers for lupus Withdrawn 02-Aug-2012 0000000000
US-20130331283-A1 Auto-antigen biomarkers for lupus Abandoned 15-Oct-2010 00000000000 0
JP-2013539863-A Autoantigen biomarkers for lupus Pending 15-Oct-2010 00000000000 0
EP-2628010-A2 Auto-antigen biomarkers for lupus Withdrawn 15-Oct-2010 G01N33/6893

Sense Proteomic Executive Team (4)

Name Title Board Seat Contact Info
Rachel Fallon Director
You’re viewing 1 of 4 executive team members. Get the full list »

Sense Proteomic Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sense Proteomic Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Apax Partners PE/Buyout Majority 000 0000 000000 0
Oxford Spin-out Equity Management Venture Capital Minority 000 0000 000000 0
Oxford University Innovation University Minority 000 0000 000000 0
SolGreen Corporation Majority 000 0000 000000 0
University of Cambridge Endowment Limited Partner 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »